Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.19 %Nav, as on 13-11-2025

  • Previous Nav

  • Net Change on 13-11-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 0.22 -0.86 4.13 21.43 15.75 19.67
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth Jul 10, 2019 4.13 21.43 15.75 2.32 847.28
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 4.00 21.60 17.66 1.82 8,346.49
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 8.55 27.41 20.59 1.87 6,437.36
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 5.26 24.77 19.32 1.93 4,082.13
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -1.90 21.15 17.34 1.93 3,143.91
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 4.55 20.75 17.34 1.93 2,821.22

Fund Holdings as on 31-October-2025

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Cipla Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Abbott India Limited

  • Torrent Pharmaceuticals Limited

  • Ajanta Pharmaceuticals Limited

  • Clearing Corporation of India Limited

  • IPCA Laboratories Limited

  • Aurobindo Pharma Limited

  • Mankind Pharma Ltd

  • J.B. Chemicals & Pharmaceuticals Limited

  • Emcure Pharmaceuticals Ltd

  • Jupiter Life Line Hospitals Ltd

  • Thyrocare Technologies Limited

  • Alkem Laboratories Limited

  • Divi's Laboratories Limited

  • SAI Life Sciences Ltd

  • ALEMBIC PHARMACEUTICALS LIMITED

  • Shilpa Medicare Ltd

  • Medi Assist Healthcare Services Ltd

  • METROPOLIS HEALTHCARE LIMITED

  • ANTHEM BIOSCIENCES LIMITED

  • Dr. Reddys Laboratories Limited

  • Procter & Gamble Health Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Suraksha Diagnostic Ltd

  • Jubilant Pharmova Ltd

  • Biocon Limited

  • Gland Pharma Limited

  • SANOFI CONSUMER HEALTHCARE

  • Piramal Pharma Ltd

  • Pfizer Limited

  • Max Healthcare Institute Limited

  • Vinati Organics Limited

  • Vijaya Diagnostic Centre Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Chemicals

View More

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹847.28 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.06(0.19%)yesterday to ₹31.28.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111